Elucidating the role of RNA splicing in the metastatic seeding and outgrowth of aggressive cancers.
阐明 RNA 剪接在侵袭性癌症的转移播种和生长中的作用。
基本信息
- 批准号:10665061
- 负责人:
- 金额:$ 4.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-13 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAlternative SplicingAutomobile DrivingBindingBioinformaticsBiologyBreastBreast Cancer CellBreast cancer metastasisCancer EtiologyCell SurvivalCellsCessation of lifeClinicalClinical ResearchCoiled-Coil DomainComplexDataDevelopmentDiseaseDisseminated Malignant NeoplasmDistalEpigenetic ProcessEventFibroblastsFoundationsFutureGenesGeneticGoalsGrantHeterogeneityImmune EvasionImmunologic SurveillanceIn VitroIndividualIntegrinsInternationalInvadedInvestigationLearningLigaseMalignant NeoplasmsMediatingMentorsMentorshipMetastatic breast cancerMethodsMolecularNeoplasm MetastasisOrganPaperPatient-Focused OutcomesPhasePhenotypePlayPopulationPostdoctoral FellowPrimary NeoplasmProcessProliferatingProtein IsoformsProteinsRNARNA ProcessingRNA SplicingRNA-targeting therapyRegulationRelapseResearchResearch ActivityResearch InstituteResearch Project GrantsResearch ProposalsRoleScientistSignal TransductionSiteT-LymphocyteTechniquesTherapeuticTissuesTranscriptUnited StatesUntranslated RNAValidationVariantWorkWritingangiogenesiscancer cellcancer stem cellcareercrosslinking and immunoprecipitation sequencingimprovedin vivomalignant breast neoplasmmeetingsneoplastic cellnovelnovel therapeutic interventionoverexpressionpost-doctoral trainingpotential biomarkerpre-doctoralpreclinical studyprogramsresponseself-renewalskillsstem cell biomarkersstudent mentoringsymposiumtargeted treatmenttherapeutic targettooltranscriptome sequencingtranscriptomicstriple-negative invasive breast carcinomatumor growthtumor initiationtumor microenvironmenttumorigenic
项目摘要
Project Summary/Abstract
Metastasis is the process in which disseminated tumor cells (DTCs) spread to distal tissues and organs, and it
is the leading cause of cancer-related deaths. In order to complete the metastatic cascade, DTCs must be able
to invade distal sites, initiate tumor growth, proliferate, and promote a tumor microenvironment (TME) to evade
immune surveillance and promote angiogenesis. Elucidating novel mechanisms that underlie these metastatic
phenotypes in DTCs can identify key drivers of metastasis, as well as potential therapeutic vulnerabilities which
can better target metastatic tumors. My dissertation research focuses on elucidating the mechanisms in which
the lncRNA BORG (BMP/OP-Responsive Gene) drives breast cancer (BC) metastasis. My studies determined
that metastatic BC cells are reliant upon BORG complexing with E3 SUMO ligase TRIM28 to induce breast
cancer stem cells (BCSCs) to expand and self-renew both in vitro and in vivo. This work establishes BORG as
a novel driver of BCSCs, and therefore increases our understanding of the mechanisms driving the accumulation
of these malignant cell populations. My recent preliminary data suggests BORG:TRIM28 complexes
downregulate the expression of splicing factors in BC cells, which contributes to BCSC phenotypes. Interestingly,
accumulating evidence indicates that dysregulation of RNA splicing, a complex molecular tool that can control
cellular phenotypes through transcriptomic regulatory mechanisms, contributes to a variety of tumorigenic
phenotypes and even metastatic relapse. Therefore, during the F99 portion of this proposal, I seek to elucidate
the mechanism whereby BORG:TRIM28 complexes dysregulate RNA splicing operant in driving metastatic and
BCSC phenotypes in BC. To complete this research during my dissertation, I will (i) determine which splicing
factors dysregulated by BORG:TRIM28 complexes drive metastatic phenotypes in BC in vitro and in vivo, and
(ii) use RNAseq and subsequent validation to determine the specific alternative splicing events affected by a
subset of these splicing factors in BORG-expressing cells. This work will identify novel mechanisms of RNA
splicing regulation that play key roles in metastatic phenotypes of BC cells. During the K00 phase of this proposal,
I plan to work closely with my postdoctoral mentor to elucidate the mechanisms in which RNA splicing contributes
to tumor cell crosstalk with the TME to promote immune evasion and subsequent metastatic outgrowth.
Specifically, I plan to elucidate (i) how alternative splicing in tumor cells drive changes in the metastatic TME to
promote immune evasion, and (ii) how alternative splicing changes in TME cells, such as T cells and fibroblasts,
contribute to the metastatic niche and subsequent metastatic outgrowth. The current and future goals of my
research are to elucidate mechanisms in which dysregulated RNA splicing contributes to metastatic seeding and
outgrowth in aggressive cancers. My predoctoral and postdoctoral research will provide me with expertise in the
role of RNA splicing in cancer metastasis, and provide me with essential research and professional skills to
launch me into my independent research career at a leading research institute.
项目概要/摘要
转移是播散性肿瘤细胞(DTC)扩散到远端组织和器官的过程,
是癌症相关死亡的主要原因。为了完成转移级联,DTC 必须能够
侵入远端部位,启动肿瘤生长、增殖并促进肿瘤微环境(TME)逃避
免疫监视并促进血管生成。阐明这些转移背后的新机制
DTC 中的表型可以识别转移的关键驱动因素,以及潜在的治疗漏洞
可以更好地靶向转移肿瘤。我的论文研究重点是阐明其中的机制
lncRNA BORG(BMP/OP 响应基因)驱动乳腺癌 (BC) 转移。我的学业决定了
转移性 BC 细胞依赖于 BORG 与 E3 SUMO 连接酶 TRIM28 的复合来诱导乳腺癌
癌症干细胞(BCSC)在体外和体内均能扩增和自我更新。这项工作将 BORG 确立为
BCSC 的新驱动因素,因此增加了我们对驱动积累机制的理解
这些恶性细胞群。我最近的初步数据表明 BORG:TRIM28 复合物
下调 BC 细胞中剪接因子的表达,从而导致 BCSC 表型。有趣的是,
越来越多的证据表明 RNA 剪接的失调,这是一种复杂的分子工具,可以控制
通过转录组调控机制的细胞表型,有助于多种致瘤
表型甚至转移复发。因此,在本提案的 F99 部分中,我试图阐明
BORG:TRIM28 复合物失调 RNA 剪接操作以驱动转移和
BC 中的 BCSC 表型。为了在我的论文期间完成这项研究,我将(i)确定哪种剪接
BORG:TRIM28 复合物失调的因素在体外和体内驱动 BC 的转移表型,以及
(ii) 使用 RNAseq 和随后的验证来确定受 a 影响的特定选择性剪接事件
BORG 表达细胞中这些剪接因子的子集。这项工作将确定 RNA 的新机制
剪接调节在 BC 细胞的转移表型中发挥关键作用。在该提案的 K00 阶段,
我计划与我的博士后导师密切合作,阐明 RNA 剪接的作用机制
肿瘤细胞与 TME 相互作用,促进免疫逃避和随后的转移生长。
具体来说,我计划阐明 (i) 肿瘤细胞中的选择性剪接如何驱动转移性 TME 的变化
促进免疫逃避,以及 (ii) TME 细胞(如 T 细胞和成纤维细胞)中的选择性剪接如何变化,
有助于转移生态位和随后的转移生长。我现在和未来的目标
研究的目的是阐明RNA剪接失调导致转移性播种和转移的机制。
侵袭性癌症的生长。我的博士前和博士后研究将为我提供以下方面的专业知识
RNA剪接在癌症转移中的作用,并为我提供必要的研究和专业技能
让我在一家领先的研究机构开始我的独立研究生涯。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kimberly Parker其他文献
Kimberly Parker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kimberly Parker', 18)}}的其他基金
Elucidating the role of RNA splicing in the metastatic seeding and outgrowth of aggressive cancers.
阐明 RNA 剪接在侵袭性癌症的转移播种和生长中的作用。
- 批准号:
10527482 - 财政年份:2022
- 资助金额:
$ 4.32万 - 项目类别:
IncRNA BORG Mediates Alternative Splicing to Enhance Cellular Plasticity in TNBC
IncRNA BORG 介导选择性剪接以增强 TNBC 中的细胞可塑性
- 批准号:
10153025 - 财政年份:2021
- 资助金额:
$ 4.32万 - 项目类别:
IncRNA BORG Mediates Alternative Splicing to Enhance Cellular Plasticity in TNBC
IncRNA BORG 介导选择性剪接以增强 TNBC 中的细胞可塑性
- 批准号:
10350611 - 财政年份:2021
- 资助金额:
$ 4.32万 - 项目类别:
相似国自然基金
GSE1选择性剪接激活PI3K/Akt通路调控脂质代谢影响衰老进程的机制研究
- 批准号:82360286
- 批准年份:2023
- 资助金额:32.2 万元
- 项目类别:地区科学基金项目
PTBP1选择性剪接对Nogo/NgR信号的影响及其在PTSD靶向治疗中的作用与机制研究
- 批准号:82372508
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
UHRF1/DNMT1-MZF1轴调控PRSS3选择性剪接影响非小细胞肺癌功能异质性的表观机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
mRNA选择性剪接和2′-O-甲基化修饰对植物抗病基因多样性影响及对抗病功能调控的研究
- 批准号:32170218
- 批准年份:2021
- 资助金额:61 万元
- 项目类别:面上项目
遗传变异调控选择性剪接影响肺腺癌发生的分子流行病学研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
- 批准号:
10750357 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别:
Understanding the Role of GARP Proteins in Rod Outer Segment Disc Formation and Retinal Degeneration
了解 GARP 蛋白在视杆外节盘形成和视网膜变性中的作用
- 批准号:
10748725 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 4.32万 - 项目类别: